Announced details
Diabetic nephropathy; diabetic endothelial dysfunction
Research relationship involving the joint analysis of the pharmacological effects of SMTP compounds.
An educational corporation. It is stated to have the Graduate School of Pharmacy and the Center for Pharmacological Sciences at Showa Medical University. Other information, including its location, representative, capital and year of establishment, is not disclosed.
Kansai University Senriyama Campus (conference venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
146th Annual Meeting of the Pharmaceutical Society of Japan
| Item | Details |
|---|---|
| Names of Products / Services Covered | SMTP-44D |
| Counterparty | Educational Corporation Showa Medical University |
| Counterparty overview | An educational corporation. It is stated to have the Graduate School of Pharmacy and the Center for Pharmacological Sciences at Showa Medical University. Other information, including its location, representative, capital and year of establishment, is not disclosed. |
| Relationship with the Company | Research relationship involving the joint analysis of the pharmacological effects of SMTP compounds. |
| Launch date | Scheduled for presentation on 27 March 2026 and 29 March 2026 |
| Applicable area | Diabetic nephropathy; diabetic endothelial dysfunction |
| Location | Kansai University Senriyama Campus (conference venue) |
| Source | 146th Annual Meeting of the Pharmaceutical Society of Japan |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To present 2 research findings on the pharmacological effects of SMTP compounds jointly analyzed by the company and Showa Medical University at the 146th Annual Meeting of the Pharmaceutical Society of Japan.